ST
ARNA

Sphinx Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sphinx Trading’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$139K Buy
+1,500
New +$98.8K 0.14% 69

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sphinx Trading's ARNA Position: Q4 2021 in Review

Sphinx Trading opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q4 2021: 1,500 shares worth $139K. The stake represents 0.14% of the portfolio and ranks #69 among its holdings.

316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Sphinx Trading held 1,500 shares of Arena Pharmaceuticals Inc worth $139K as of Q4 2021.
  • Arena Pharmaceuticals Inc was a new Sphinx Trading position in Q4 2021.
  • Arena Pharmaceuticals Inc made up 0.14% of Sphinx Trading's portfolio in Q4 2021, its #69 holding.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Sphinx Trading's 13F filing for Q4 2021, filed 31 Jan 2022.